The market for Stent graft balloon catheters is growing with the expansion of this Industry Sector Worldwide. Fact.MR has added a new report titled “Stent Graft Balloon Catheter Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” which offer details about the current trends as well as scope for the Stent graft balloon catheters in the near future. This research study also covers information about the production and market share based on different active regions. Furthermore, an anticipated growth at a double-digit CAGR for the concerned sector is highlighted in the report which indicates a prosperous future.
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=149
Stent graft balloon catheters are soft catheters equipped with inflatable balloons, and are utilized during a catheterization process, in order to enlarge the narrow opening in coronary artery. Stent graft balloon catheter are generally used to expand vascular prosthesis, or at times of temporary occlusion of huge vessels, thereby utilized in several endovascular treatment of thoracic, aortic, and abdominal diseases.
Usually, stent graft balloon catheters are adopted in balloon angioplasty and bypass graft surgery. These stents prevent risks related to re-narrowing that occurs in several patients undergoing angioplasty, as well as risks associated with abrupt artery closure. On the back of these benefits, demand for stent graft balloon catheters is on a rise. The market for stent graft balloon catheter has witnessed a gradual evolution from simple stents to the modified balloon stent catheters. Over the recent past, number of hospital admissions has witnessed a surge, owing to rising incidences of atherosclerosis, and growing prevalence of coronary artery disease (CAD) around the world. A number of technological developments have been observed in balloon catheters, coupled with the rise in healthcare expenditure.
9 Key Estimations from Fact.MR’s Report on the Global Stent Graft Balloon Catheter Market:
1- Based on raw material, sales of polyurethane for producing stent graft balloon catheters will register a steady expansion, while sales of nylon are estimated to register a sluggish growth through 2022.
2- Cardiac catheterization laboratories are anticipated to become the fastest growing end-users in the global stent graft balloon catheter market.
3- Ambulatory surgical centres are expected to be the least lucrative end-users of stent graft balloon catheters.
4- Hospitals will continue to be the largest end-user segment, with sales poised to reach nearly US$ 900 Mn by 2022-end.
5- Sales of stent graft balloon catheters for coronary artery disease indication are projected to account for over two-third share of the market over the forecast period, in terms of revenues.
6- Demand for stent graft balloon catheters from peripheral vascular disease indication segment will remain sluggish in the market.
7- Although, the market in Middle East & Africa (MEA) is expected to register a sluggish expansion, sales of stent graft balloon catheter in this region are estimated to gain an uptick by 2022-end.
8- Europe will continue to be the largest market for stent graft balloon catheter, with sales projected to exceed US$ 400 Mn in revenues by 2022-end.
9- Key players contributing to growth of the market include Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Hexacath, Cardionovum GmbH, Jotech GmbH, MicroPort Scientific Corporation, Boston Scientific Corporation, Terumo Corporation, Cook Medical INC, B. Braun Melsungen AG, Cordis Corporation, and Medtronic Plc.
Browse Full Report with TOC- https://www.factmr.com/report/149/stent-graft-balloon-catheter-market
Europe to be the Most Attractive Market for Stent Graft Balloon Catheter
Europe is estimated to be the most attractive market for stent graft balloon catheter. Asia-Pacific excluding Japan (APEJ) is expected to exhibit the highest CAGR in the global market through 2022. By indication, coronary artery disease will continue to account for a comparatively larger revenue share of the market than peripheral vascular disease.
Based on end-users, hospitals will retain their dominance in the global stent graft balloon catheter market during 2017 to 2022. However, sales of stent graft balloon catheter in cardiac catheterization laboratories will continue to exhibit the fastest expansion at 5.1% CAGR through 2022.
Competition Tracking
Market players listed in Fact.MR’s report on the global market for stent graft balloon catheter include Medtronic Plc, Cordis Corporation, B. Braun Melsungen AG, Cook Medical INC, Terumo Corporation, Boston Scientific Corporation, MicroPort Scientific Corporation, Jotech GmbH, Cardionovum GmbH, Hexacath, Abbott Laboratories, and Meril Life Sciences Pvt. Ltd.
Request Discount On This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=149
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/